Related Experiment Video
Updated: Jun 8, 2026
09:45
Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
Postoperative cognitive dysfunction: toward the Alzheimer's disease pathomechanism hypothesis
Federico Bilotta1, Andrea Doronzio, Elisabetta Stazi
1Department of Anesthesiology, Critical Care and Pain Medicine, University of Rome "La Sapienza", Italy. bilotta@tiscali.it
Journal of Alzheimer'S Disease : JAD
|October 9, 2010
Summary
Anesthesia may influence Alzheimer's disease (AD) progression by affecting brain mechanisms like apoptosis. Research is exploring links between anesthesia, neurodegeneration, and cognitive dysfunction.
Area of Science:
- Neuroscience
- Gerontology
- Anesthesiology
Background:
- Alzheimer's disease (AD) is the most common dementia, characterized by progressive cognitive decline.
- Growing interest exists in the potential relationship between anesthesia and neurodegenerative disorders like AD.
- Preclinical and clinical research aims to identify risk factors and mechanisms linking anesthesia to neurodegeneration.
Purpose of the Study:
- To investigate the potential relationship between anesthesia and the onset/progression of Alzheimer's disease.
- To explore shared pathomechanisms between anesthesia and neurodegenerative disorders.
- To identify strategies for minimizing neurodegenerative disorder incidence related to anesthesia.
Main Methods:
- Review of preclinical studies examining anesthetic effects on neuronal apoptosis.
- Analysis of research on misfolded protein accumulation in the aging brain.
- Evaluation of clinical data on postoperative cognitive dysfunction.
Main Results:
- Preclinical evidence suggests anesthetics can induce neuronal apoptosis.
- Anesthetics may contribute to the accumulation of misfolded proteins in aging brains.
- Overlapping risk factors and pathomechanisms exist between AD and postoperative cognitive dysfunction.
Conclusions:
- Anesthesia may play a role in the pathogenesis or progression of Alzheimer's disease.
- Understanding these links can inform safer anesthetic practices.
- Further research is needed to clarify the precise relationship and develop preventive strategies.
Related Concept Videos
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.